World-leading plasma companies collaborate to accelerate the development of a potential COVID-19 hyperimmune therapy.

Takeda has been working intensively on the development of a potential plasma-derived therapy for the treatment of COVID-19 since the beginning of the corona crisis. At the beginning of April, Takeda Pharmaceutical Company Limited and CSL Behring announced the establishment of a global plasma alliance to accelerate the development of a potential therapy to treat people with serious complications from COVID-19. Four other plasma companies have already joined the alliance, such as Biotest, BPL, LFB, and Octapharma.

“Unprecedented times call for bold moves,” said Julie Kim, President of Plasma-Derived Therapies Business Unit, Takeda. “We collectively agree that by collaborating and bringing industry resources together, we could accelerate bringing a potential therapy to market as well as increase the potential supply. We invite companies and institutions focusing on plasma to support or join our alliance.”

Thomas R. Kreil, Head of Global Pathogen Safety at Takeda explains: “The Takeda manufacturing site in Vienna has a 65-year history in the development and production of plasma-derived therapies from which we now benefit for the development of a possible therapy. The global alliance of leading plasma companies to develop a treatment for COVID-19 is an important step. It is no longer a question of who comes first to the market, but that everyone, together, increases the pace, bundles experience and efforts, and that larger amounts of treatment become available. The result will be a drug that belongs to everyone.”

Developing a hyperimmune requires plasma donations from many individuals who have fully recovered from COVID-19, and whose blood contains antibodies that can fight the novel coronavirus. Once collected, the “convalescent” plasma would then be transported to manufacturing facilities where it undergoes proprietary processing, including effective virus inactivation and removal processes, and then is purified into the product.


How to become a COVID-19 lifesaver in Austria

If you have fully recovered from COVID-19 call +43 (0) 120 609 2538 or send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. and make an appointment for a plasma donation in one of our Takeda plasma centers in Austria, called BioLife. Feel free to share this information within your network and get more details on


Plasma donation is a safe process and more important than ever for patients in times of COVID-19

Donating plasma is a very safe process. Due to the current situation, the security measures in our BioLife centers in Austria have been tightened again – among other things, through additional and comprehensive hygiene and disinfection measures and the increase in social distancing in the waiting and reception area as well as in the dispenser room. The safety of donors our top priority. Despite the current restrictions in public life, plasma donations are permitted and are also clearly supported by the authorities in Austria.

Anyone can come into a situation where the administration of a plasma-based therapy becomes necessary. This can be, for example, in the context of a medical emergency, such as an accident, during an operation or after severe burns. This is made possible by the so-called fibrin glue, which can be used, among other things, for tissue bonding, hemostasis and to promote wound healing. Blood plasma also helps patients who are dependent on plasma-derived products due to an immune disorder, such as an immune deficiency or rare disease. These people often have a weakened immune system and belong to the risk group of COVID-19. It is more important than ever that they continue to receive their therapies, and everyone can contribute to this by donating plasma.


About Takeda in Austria

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.

The facilities of Takeda in Austria have a long history. What began in 1778 is today a the largest pharmaceutical employer in Austria and thus an important part of the domestic pharmaceutical industry. Takeda Austria serves the entire value chain: from Research & Development, sourcing human blood plasma in twelve plasma centers in Austria, through the production of medicines from human plasma and recombinant products, to the worldwide shipping of finished products. The domestic research and production facilities are located in Vienna, Linz and Orth an der Donau.

Everyday, round 4,500 employees contribute to bringing medicines from Austria to more than 100 countries worldwide and giving people in Austria access to Takeda's innovative medicines. The product portfolio helps Austrian patients in areas such as oncology, gastroenterology, immunology, hemophilia and genetic diseases. Learn more about Takeda in Austria.


Manufacturing in Vienna   Manufacturing Vienna1   Manufacturing Vienna6

  • FEMS - Get Involved bulletin – November 2021
    The FEMS Get involved bulletin is out! Read the October issue with microbiology research, events and calls. In this bulletin: FEMS Industry Placement Grants Congress Attendance Grant Meeting Organizer Grant, Research and Training Grant New podcast episode FEMS Journal News Opportunities and other news   The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like FEMS. ÖGMBT members are automatically members of…
  • FEMS Affiliates Letter - November 2021
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of November 2021 has the following content:   1. Microbiology News and Events 2. The FEMS Journals 3. Policy Corner 4. Grants Corner 5. Opportunities 6. Extras    
  • LS2 Annual Meeting 2022
    LS2 Annual Meeting 2022 on the topic “Life Sciences in the 2020s: quantitation, integration and prediction", will be held on February 17 and 18, 2022, together with the Young Scientists' Satellite on February 16, 2022 in Zurich, at campus Irchel of the University of Zurich. The program will include 3 plenary lectures, Nevan Krogan (University of California San Francisco), Anne-Claude Gingras (Lunenfeld-Tanenbaum Research Institute. Toronto) and Marnix H. Medema (Wageningen…
  • FEMS Grant for industry placement
    As Early Career Scientist, you can apply similar to a Research & Training Grant, but with an industry of your choice as your host. Also non-laboratory work can be considered, as long as relevant for microbiology (ie communications, patenting, quality control, advocacy, etc). What are you waiting for? Get in touch with the industry of your choice and start creating a working plan. Next deadline is February 1st 2022. More…
  • FEMS Affiliates Letter - October 2021
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of October 2021 has the following content:   1. Microbiology News and Events 2. The FEMS Journals 3. Grants Corner 4. Opportunities 5. Extras
  • FEMS - Get Involved bulletin – October 2021
    The FEMS Get involved bulletin is out! Read the October issue with microbiology research, events and calls. In this bulletin: FEMS Industry Placement Grants FEMS Conference in Belgrade 2022 FEMS Journal News Grants corner, opportunities and other news   The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like FEMS. ÖGMBT members are automatically members of these societies and are entitled to…
  • ÖGMBT members can now choose to publish open access articles in two FEBS journals
    FEBS is pleased to announce that ÖGMBT members can now choose to publish open access articles in two FEBS  journals (The FEBS Journal and FEBS Letters) at no direct cost. In February 2021, Wiley, FEBS’ publishing partner, agreed a 3-year combined open access publication and subscription agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Researchers at affiliated institutes will be able to both access…
  • EMBO Women in Science Award - Deadline 15th October
    Nominations are invited for the 2022 FEBS | EMBO Women in Science Award.  The deadline is next Friday, 15th October. Full details can be seen here:
  • ÖGMBT congratulates Markus Schosserer!
    Welche Veränderungen durchlebt unser Organismus, während wir altern? Die Biotechnologen Johannes Grillari und Markus Schosserer haben es sich zur Aufgabe gemacht, dem gesunden Altwerden auf Zellebene auf die Spur zu gehen. Inzwischen ist es ihnen gelungen, das Leben von Fliegen, Würmern und Hefezellen zu verlängern und gleichzeitig deren Fitness zu steigern. Dies gelang durch Veränderungen an den Ribosomen.   Originalartikel
  • FEMS Affiliates Letter - September 2021
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of September 2021 has the following content:   1. Microbiology News and Events 2. The FEMS Journals 3. Policy Corner 4. Grants Corner 5. Opportunities 6. Extras  
  • Present-Day Practicals symposium from LabBuddy
    On the 27th of January 2022, we welcome you to the 4th edition of the Present-Day Practicals symposium. During this interactive (online) event you will get the chance to get inspired by (international) colleagues, and to learn from both their challenges and their successes. Together, we will discuss the lessons learned and highlight opportunities for future laboratory teaching. The Present-day Practicals symposium aims at increasing the quality of laboratory education based on recent…
  • Winter School Revise & Revitalize- LBG Career Center
    From 8 – 12 February 2021, the LBG Career Center is offering an inaugural 5-day Winter School for pre- and post-docs of the Ludwig Boltzmann Gesellschaft as well as other research organizations and universities. The goal of the Winter School Revise & Revitalize is to demystify the unwritten rules of writing and presenting to enable researchers to communicate their research successfully.
  • YSF (Young Scientists Forum) 2022 Portugal
    2022 IUBMB–FEBS–PABMB Young Scientists’ Forum (YSF 2022) will be held just ahead of – and in conjunction with – the joint 25th IUBMB, 46th FEBS and 15th PABMB Congress. The exciting YSF 2022 will take place at Vimeiro, located on the Portuguese coast alongside a peaceful beach with a fantastic view of the endless Atlantic Ocean. The YSF 2022 meeting will bring together around 120 selected young researchers in biochemistry…
  • Neues Leadership-Programm für Innovatorinnen
    Jetzt bewerben für INNOVATORINNEN LEADERSHIP Anfang 2022 startet der neue, von der FFG (Österreichische Forschungsförderungsgesellschaft) begleitete Durchgang für Gestalterinnen (powered by BMDW). Für alle, die ihre F&I-Missionen entfalten, neue Netzwerk-Kontakte aufbauen und zu mehr beruflichen Gestaltungsspielräumen gelangen möchten. Am 2.Dezember gibt die FFG Einblick in die Bewerbungsmöglichkeit bei einem Info-Webinar. INNOVATORINNEN ist Empowerment und Peer-Group-Austausch kombiniert mit Innovationssession (z.B.  Co-Creation, Visual-, System- & Design-Thinking, LEGO© Serious Play©), um Innovatorinnen und…
  • IUBMB grants
    IUBMB grants- There is variety of travel and fellowship grants for young researchers from International Union of Biochemistry and Molecular Biology with upcoming deadlines.  Check it out here.
  • FEBS-IUBMB-ENABLE 2022 Symposium – a PhD and Postdoc meeting
    FEBS-IUBMB-ENABLE are now looking for an academic institution (either a university or a research institution) in Europe with a strong research background in molecular life sciences and an active PhD community to host the November 2022 conference. This event will be organized by a committee of young researchers belonging to the four ENABLE institutions (core institutions, as listed above) plus the selected host institution (associated institution). It will be organized…
  • FEBS junior initiative
    To bring together young scientists from all over Europe, the junior sections of the ÖGMBT (Austria), SIB (Italy), SEBBM (Spain) and GBM (Germany) have collaborated with FEBS to establish a platform for exchange within the FEBS Network. For this, FEBS has created an open Room for the Junior Sections of FEBS Constituent Societies. All young members from the FEBS societies are welcome to sign up to the FEBS Network and become a member of the room using the following…
  • Explaining THT Biomaterials in 3 Minutes to Scientists
    This is our supplemental 3 minute video for the 11th World Congress on Alternatives and Animal Use in the Life Sciences (WC11) from 23 August - 2 September 2021, our abstract ID=625: Enjoy watching (and sorry for the poor sound - we will improve)!
  • Summer School LEAD_able from LBG career center
    LINK: Das LBG Career Center bietet im Sommer 2020 zum zweiten Mal eine Summer School für Pre- und Post-Docs (NachwuchswissenschafterInnen) der Ludwig Boltzmann Gesellschaft, sowie anderer Forschungsorganisationen und Universitäten an. Das Ziel der intensiven 6-tägigen Summer School LEAD_able ist, sich kompakt Transferable Skills für eine (Führungs-)Karriere in oder außerhalb der Wissenschaft anzueignen und professionell begleitet über die individuelle Karriereentwicklung zu reflektieren.  Skills Trainings zu 4 Themenschwerpunkten, ein spezielles GENtoring (alters-, geschlechts-…
  • Journal “Cell Communications and Signaling” invites you to submit abstracts
    Journal "Cell Communications and Signaling" invites you to submit to our new thematic series: Extracellular Vesicles in Infectious Disease   This new thematic series focuses on the role of EVs in bacterial and viral infections. This includes EVs released from infected host cells that contain antimicrobial compounds, outer membrane vesicles (OMVs) derived from bacterial pathogens or viruses, which strongly resemble mammalian EVs. Increasing knowledge of pathogen- and host cell-derived EVs…
  • Wie die Gedanken so das Verhalten
    Eine Zeitung zu lesen, egal ob im Internet oder ausgedruckt, ist wie einem Menschen zuzuhören. Stell dir vor, du hörst permanent einem notorischen Nörgler zu, der immer und überall ein Haar in der Suppe findet, der sich an nichts freuen kann, der nur Probleme sieht, der nur von den schlechten Seiten der Menschen erzählt. Welches Weltbild würdest du...
  • Trockenheit durch Verlust der Schneedecke
    Der fehlende Schnee verschärft neben der Verstädterung und dem steigenden Wasserbedarf in Landwirtschaft und Industrie zusätzlich die Ausmaße der Trockenheit. Der Iran leidet nach Angaben der Vereinten Nationen seit fast 30 Jahren unter Dürre, wobei sich die Situation zunehmend verschärft. Eine neue Studie der Universität Graz in Zusammenarbeit mit...
  • Invasive Säugetiere als Gefahr für Gesundheit
    Invasive Säugetiere können in Europa auch zur Gefahr für Gesundheit und Biodiversität werden. Die Verbreitung eingeschleppter Arten und potenzieller Krankheitserreger wird durch den Klimawandel begünstigt.Invasive Säuger verdrängen heimische ArtenWaschbär, Marderhund, Grauhörnchen, Nutria – putzige Säugetiere, die eines gemeinsam haben: Sie kamen u...
  • Inactivated Covid-19 vaccine of Valneva is expected for 2nd Q 2022
    Valneva SE has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate, VLA2001, over two years. Valneva expects to deliver 24.3 million doses during the second and third quarters of 2022, subject to approval of VLA2001 by the European Medicines...
  • Uni Innsbruck beweist hohes Potenzial für Firmengründungen
    Mit 11 Spin-offs in der Zeit von 2018 – Juni 2021 liegt die Uni Innsbruck vor allen anderen österreichischen Universitäten. In der Gesamtwertung der „Leading Austrian Institutions“, die im Rahmen der Spin-Off-Austria-Konferenz 2021 ausgezeichnet wurden, belegte die Universität Innsbruck den 3. Platz. Insgesamt waren 51 Universitäten und...
  • Aufbruch in eine neue Welt
    Aufbruch in eine Neue Welt NOISIV im Tempel der Macht widmet sich in jedem Kapitel einem ganz spezifischen Thema, das uns im täglichen Leben nur allzuoft begegnet. Es sind Verhaltensweisen skizzenhaft beschrieben, die nur allzu menschlich sind. Wenn Du mit etwas Distanz darauf blickst, wird es Dir vielleicht selbst seltsam vorkommen, wie wir uns...
  • Menschliches Wohlergehen anstelle von Wirtschaftswachstum
    Im Wettlauf an die ökologischen Grenzen unseres Planeten stellte ein britisch- österreichisches Forschungsteam 148 Länder auf dem Prüfstand. Kein Land der Erde erreichte in den vergangenen drei Jahrzehnten soziale Mindestanforderungen, ohne dabei ökologische Grenzen zu übertreten. Das fand ein britisches Forschungsteam unter Beteiligung der BOKU...
  • Keine Panik vor der Angst
    “Vielleicht haben sie Angst davor, sich die Angst selbst einzugestehen? Sie haben Angst, als schwach abgestempelt zu werden. Dabei erfordert es ganz schön viel Mut und Stärke, der Angst vorbehaltlos in die Augen zu sehen.”Seite 37Nur keine Panik vor der Angst. Angst ist ein archaisches Gefühl, das den Menschen seit Jahrtausenden vor...
  • Anapur AG
    anapur AGVirtueller Dialog –Computersystem meets GxP // Entwicklungen, Chancen, Risiken23. Nov. 202115:30 – 17.30 UhrUnternehmen müssen sich laufend an Entwicklungen in ihrem Umfeld anpassen, auch in regulierten Bereichen. Diese Entwicklungen können positiv sein, wie neue Technologien die effizientere Prozesse ermöglichen. Sie können aber auc...
  • Willkommen bei life-science
    Jobbörse und Netzwerk für Naturwissenschaftler /-innen.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px...